PRTC vs. ERGO, OXB, SLN, FARN, HZD, VRP, ARIX, AVCT, CIR, and BVXP
Should you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Ergomed (ERGO), Oxford Biomedica (OXB), Silence Therapeutics (SLN), Faron Pharmaceuticals Oy (FARN), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Avacta Group (AVCT), Circassia Group (CIR), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry.
PureTech Health vs. Its Competitors
PureTech Health (LON:PRTC) and Ergomed (LON:ERGO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.
Ergomed has a net margin of 9.87% compared to PureTech Health's net margin of -17,620.94%. Ergomed's return on equity of 18.08% beat PureTech Health's return on equity.
53.1% of PureTech Health shares are owned by institutional investors. Comparatively, 71.1% of Ergomed shares are owned by institutional investors. 13.1% of PureTech Health shares are owned by company insiders. Comparatively, 18.2% of Ergomed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Ergomed has higher revenue and earnings than PureTech Health. Ergomed is trading at a lower price-to-earnings ratio than PureTech Health, indicating that it is currently the more affordable of the two stocks.
PureTech Health currently has a consensus price target of GBX 455, indicating a potential upside of 268.12%. Given PureTech Health's stronger consensus rating and higher probable upside, research analysts clearly believe PureTech Health is more favorable than Ergomed.
In the previous week, PureTech Health's average media sentiment score of 0.00 equaled Ergomed'saverage media sentiment score.
PureTech Health has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Ergomed has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.
Summary
Ergomed beats PureTech Health on 9 of the 13 factors compared between the two stocks.
Get PureTech Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PureTech Health Competitors List
Related Companies and Tools
This page (LON:PRTC) was last updated on 8/30/2025 by MarketBeat.com Staff
